Trial unpredictability yields predictable therapy gains
- 21 August 2013
- journal article
- Published by Springer Nature in Nature
- Vol. 500 (7463) , 395-396
Abstract
In decades of clinical-trial data, new treatments are better than standard ones just over half the time. That's as it should be, say Benjamin Djulbegovic and colleagues.Keywords
This publication has 9 references indexed in Scilit:
- Treatment Success in Cancer: Industry Compared to Publicly Sponsored Randomized Controlled TrialsPLOS ONE, 2013
- New treatments compared to established treatments in randomized trialsCochrane Database of Systematic Reviews, 2012
- Evolution of Translational Omics2012
- Avoidable waste in the production and reporting of research evidenceThe Lancet, 2009
- Articulating and Responding to Uncertainties in Clinical ResearchThe Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine, 2007
- When are randomised trials unnecessary? Picking signal from noiseBMJ, 2007
- What is the prior probability of a proposed new treatment being superior to established treatments?BMJ, 1997
- Sorting out the doctor's bagControlled Clinical Trials, 1980
- Strong InferenceScience, 1964